199 related articles for article (PubMed ID: 23652076)
1. Pyoderma gangrenosum associated with ulcerative colitis and psoriasis.
Guo H; Zhang L; An Q; Yang ZH; Li B; Gao XH; Li JH
Chin Med J (Engl); 2013; 126(9):1798. PubMed ID: 23652076
[No Abstract] [Full Text] [Related]
2. [Ulcerative colitis associated with pyoderma gangrenosum].
Tusnádi A; Uhrin K; Bényei M; Krasznai G
Orv Hetil; 1994 Apr; 135(17):917-9. PubMed ID: 7909938
[TBL] [Abstract][Full Text] [Related]
3. Three decades later: pyoderma gangrenosum and episcleritis in a patient with quiescent ulcerative colitis.
Rustagi T
Conn Med; 2014 Apr; 78(4):221-3. PubMed ID: 24830119
[No Abstract] [Full Text] [Related]
4. Response to infliximab in atypical pyoderma gangrenosum associated with ulcerative colitis.
Fernández A; Velasco A; Prieto V; Canueto J; Alvarez A; Rodríguez A
Am J Gastroenterol; 2008 Nov; 103(11):2951-2. PubMed ID: 19032482
[No Abstract] [Full Text] [Related]
5. Therapeutic hotline. Infliximab for treatment of resistant pyoderma gangrenosum associated with ulcerative colitis and psoriasis. A case report.
Baglieri F; Scuderi G
Dermatol Ther; 2010; 23(5):541-3. PubMed ID: 20868408
[TBL] [Abstract][Full Text] [Related]
6. [Ulcerative colitis concomitant with pyoderma gangrenosum and erythema nodosum--presentation of two cases].
Wojas-Pelc A; Wielowieyska-Szybińska D; Setkowicz M; Szybiński P; Bogdaszewska-Czabanowska J
Przegl Lek; 2001; 58(10):945-9. PubMed ID: 11957826
[TBL] [Abstract][Full Text] [Related]
7. Education and imaging. Gastrointestinal: severe inflammatory bowel disease-associated pyoderma gangrenosum.
Freedberg DE; Husain S; Swaminath A
J Gastroenterol Hepatol; 2013 Nov; 28(11):1691. PubMed ID: 24147454
[No Abstract] [Full Text] [Related]
8. Refractory pyoderma gangrenosum associated with ulcerative colitis successfully treated with infliximab.
Ueda M; Katoh M; Tanizaki H; Tanioka M; Matsumura Y; Miyachi Y
Dermatol Online J; 2012 Jan; 18(1):12. PubMed ID: 22301049
[TBL] [Abstract][Full Text] [Related]
9. Image of the Month. Pyoderma gangrenosum caused by ulcerative colitis.
Botros N; Pickover L; Das KM
Gastroenterology; 2000 Apr; 118(4):654, 809. PubMed ID: 10777349
[No Abstract] [Full Text] [Related]
10. Pyoderma gangrenosum of the "sinus mammarum" in ulcerative colitis.
Angiò LG; Pirrone G; Rivoli G; Fracassi MG; Rosato A; Piazzese E; Pacilé V; Sfuncia G; Fiumara F
G Chir; 2003; 24(6-7):247-54. PubMed ID: 14569923
[TBL] [Abstract][Full Text] [Related]
11. Pustular vasculitis and superficial bullous pyoderma gangrenosum in a patient with ulcerative colitis.
Lazarov A; Amichai B; Halevy S
Cutis; 1995 Nov; 56(5):297-300. PubMed ID: 8565618
[TBL] [Abstract][Full Text] [Related]
12. Coexistence of pyoderma gangrenosum and Sweet's syndrome in a patient with ulcerative colitis.
Castro-Fernández M; Sánchez-Muñoz D; Ruíz-Granados E; Merchante N; Corzo J
Am J Gastroenterol; 2007 Dec; 102(12):2865-6. PubMed ID: 18042124
[No Abstract] [Full Text] [Related]
13. [What is your diagnosis? Pyoderma gangrenosum in ulcerative colitis].
Lautenschlager S
Schweiz Rundsch Med Prax; 1993 May; 82(18):527-8. PubMed ID: 8497761
[No Abstract] [Full Text] [Related]
14. Infliximab for the treatment of disseminated pyoderma gangrenosum associated with ulcerative colitis. Case report and literature review.
Juillerat P; Christen-Zäch S; Troillet FX; Gallot-Lavallée S; Pannizzon RG; Michetti P
Dermatology; 2007; 215(3):245-51. PubMed ID: 17823524
[TBL] [Abstract][Full Text] [Related]
15. Refractory and infected pyoderma gangrenosum in a patient with ulcerative colitis: response to infliximab.
De la Morena F; Martín L; Gisbert JP; Fernández Herrera J; Goiriz R
Inflamm Bowel Dis; 2007 Apr; 13(4):509-10. PubMed ID: 17206663
[No Abstract] [Full Text] [Related]
16. Successful Use of Adalimumab for Treating Pyoderma Gangrenosum with Ulcerative Colitis under Corticosteroid-tapering Conditions.
Sagami S; Ueno Y; Tanaka S; Nagai K; Hayashi R; Chayama K
Intern Med; 2015; 54(17):2167-72. PubMed ID: 26328641
[TBL] [Abstract][Full Text] [Related]
17. The pustular eruption of ulcerative colitis.
Warin AP
Br J Dermatol; 1998 Oct; 139(4):758-9. PubMed ID: 9892937
[No Abstract] [Full Text] [Related]
18. PYODERMA GANGRENOSUM AS THE ONLY MANIFESTATION OF ASYMPTOMATIC NEWLY DIAGNOSED NONSPECIFIC ULCERATIVE COLITIS. CLINICAL CASE.
Rosul MV; Patskan BM
Wiad Lek; 2022; 75(10):2549-2553. PubMed ID: 36472297
[TBL] [Abstract][Full Text] [Related]
19. Tofacitinib, a useful option for the treatment of pyoderma gangrenosum in an ulcerative colitis patient.
Salmón Olavarría P; Rubio Iturria S; Nantes Castillejo Ó
Rev Esp Enferm Dig; 2021 Oct; 113(10):733-734. PubMed ID: 33845581
[TBL] [Abstract][Full Text] [Related]
20. 'Sticky' neutrophils, pathergic arthritis, and response to heparin in pyoderma gangrenosum complicating ulcerative colitis.
Dwarakanath AD; Yu LG; Brookes C; Pryce D; Rhodes JM
Gut; 1995 Oct; 37(4):585-8. PubMed ID: 7489951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]